RxDoctor Payments Data

Patricia White, PA

Physician Assistant · Missoula, MTNPI 1730633355

Payments from drug & device makers

$532in general payments, 2019–2025

Across 42 payments — averaging $12.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$134
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$115
  • Sunovion Pharmaceuticals Inc.$87
  • Otsuka America Pharmaceutical, Inc.$62
  • Neurocrine Biosciences, Inc.$53
  • Indivior Inc.$49
  • plus $32 from 1 others

What the payments were for

  • Food & beverage$38973%
  • Education$14327%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$532 in reported general payments places this provider in the 75th percentile of 626 physician assistant providers in Montana.

See all physician assistant providers in Montana

Medicare billing

Part B allowed, 2024
$40,574
Medicare patients
129
Services billed
607

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate34$266,106
PerserisRisperidone34$98,316
Invega SustennaPaliperidone Palmitate23$46,397
VraylarCariprazine Hcl33$33,922
Abilify MaintenaAripiprazole15$33,416
AristadaAripiprazole Lauroxil12$29,005
Clozapine258$24,344
Aripiprazole147$19,470
Paliperidone ErPaliperidone39$11,384
Lisdexamfetamine Dimesylate25$5,939
Divalproex Sodium ErDivalproex Sodium56$4,957
Asenapine Maleate15$4,781
Quetiapine Fumarate300$4,077
Bupropion XlBupropion Hcl167$4,020
VyvanseLisdexamfetamine Dimesylate11$3,867

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$53$266,10634 claims
Indivior Inc.Perseris$49$98,31634 claims
AbbVieVraylar$32$33,92233 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$62$33,41615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 626 physician assistant providers in Montana.

Other physician assistant in Missoula

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →